 Oxford, CT, Sept. 15, 2021 GLOBE NEWSWIRE -- Nxt-ID, Inc. NASDAQ: NXTD the Company, a provider of technology products and services for healthcare applications, announced today the pricing of an underwritten public offering of 27,887,500 shares of the Companys common stock, which includes 3,637,500 shares to be issued upon the exercise of the underwriters over-allotment option collectively, the Shares, and warrants to purchase up to 27,887,500 shares of the Companys common stock, which includes additional warrants to be issued upon the exercise of the underwriters over-allotment option to purchase up to an additional 3,637,500 shares of common stock collectively, the Warrants, at a combined purchase price of 0.45 per Share and Warrant. The Warrants have an initial exercise price of 0.495 per share, subject to certain adjustments, and a term of approximately five years. The gross proceeds of the offering to the Company, inclusive of proceeds from the full exercise of the over-allotment option, are expected to be approximately 12.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses. The Company granted the underwriters a 45-day option to purchase up to an additional 3,637,500 Shares and Warrants to purchase up to an additional 3,637,500 shares of common stock at the public offering price to cover over-allotments, which the underwriters exercised in full. The offering is expected to close today, subject to customary closing conditions. 